Collect. Czech. Chem. Commun.
1978, 43, 2082-2088
https://doi.org/10.1135/cccc19782082
Distribution and metabolic transformation of 9-(S)-(2,3-dihydroxypropyl)adenine, an effective virostatic agent, in mice
Alois Čihák and Antonín Holý
Crossref Cited-by Linking
- Quinn R.P., Scharver Jeff, Hill John A.: Synthesis and use of radioactive antiviral agents in radioimmunoassay and metabolism studies. Pharmacology & Therapeutics 1985, 30, 43. <https://doi.org/10.1016/0163-7258(85)90047-6>
- Remy Richard J., Secrist John A.: Acyclic Nucleosides other than Acyclovir as Potential Antiviral Agents. Nucleosides and Nucleotides 1985, 4, 411. <https://doi.org/10.1080/07328318508056172>
- Parkin Ann, Harnden Michael R.: Acyclic analogues of purine and imidazole nucleosides. Journal of Heterocyclic Chem 1982, 19, 33. <https://doi.org/10.1002/jhet.5570190104>
- Jelínek R., Holý A., Votruba I.: Embryotoxicity of 9‐(s)‐(2,3‐dihydroxypropyl)adenine. Teratology 1981, 24, 267. <https://doi.org/10.1002/tera.1420240304>
- Holy Antonin, Čihák Alois: Metabolism of 9-(S)-(2,3-dihydroxypropyl)adenine, an antiviral agent, in mice. Biochemical Pharmacology 1981, 30, 2359. <https://doi.org/10.1016/0006-2952(81)90113-1>
- De Clercq E., Leyten R., Sobis H., Matousek J., Holý A., De Somer P.: Inhibitory effect of a broad-spectrum antiviral egent, (S)-9-(2,3-dihydroxypropyl)adenine, on spermatogenesis in mice. Toxicology and Applied Pharmacology 1981, 59, 441. <https://doi.org/10.1016/0041-008X(81)90296-9>
- Kára J., Vácha P., Holý A.: 9‐(S)‐(2,3‐Dihydroxypropyl)adenine inhibits the transformation of chick embryo fibroblasts infected with rous sarcoma virus. FEBS Letters 1979, 107, 187. <https://doi.org/10.1016/0014-5793(79)80492-5>
